Literature DB >> 24824184

PFTK1 interacts with cyclin Y to activate non-canonical Wnt signaling in hepatocellular carcinoma.

Tingting Sun1, Ngai Na Co1, Nathalie Wong2.   

Abstract

PFTK1 is a Cdc2-related protein kinase that is frequently upregulated in human hepatocellular carcinoma (HCC) where it correlates with metastatic features and motile phenotypes. To understand the modulated pathway underlining the PFTK1 action, here we show a physical interaction between PFTK1 and cyclin Y (CCNY) in promoting noncanonical Wnt signaling. In HCC cells, we found PFTK1 forms a direct complex with CCNY, and together readily upregulate key components of Wnt signaling (Dvl2 and Naked1). Exogenous expression of PFTK1 and CCNY activated Rho GTPases, which are known targets of the noncanonical path. In line with Rho GTPases activation, we also found marked actin polymerizations in cells with PFTK1-CCNY co-expressions. Our findings highlight a PFTK1-CCNY complex in activating noncanonical Wnt signaling in HCC cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cell motility; Cyclin Y; Hepatocellular carcinoma; PFTK1; Wnt pathway

Mesh:

Substances:

Year:  2014        PMID: 24824184     DOI: 10.1016/j.bbrc.2014.05.002

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Upregulated PFTK1 promotes tumor cell proliferation, migration, and invasion in breast cancer.

Authors:  Xiaoling Gu; Yingying Wang; Hua Wang; Qichao Ni; Chunhui Zhang; Jia Zhu; Wei Huang; Pan Xu; Guoxin Mao; Shuyun Yang
Journal:  Med Oncol       Date:  2015-06-02       Impact factor: 3.064

Review 2.  Atypical regulators of Wnt/β-catenin signaling as potential therapeutic targets in Hepatocellular Carcinoma.

Authors:  Jianxiang Chen; Muthukumar Rajasekaran; Kam M Hui
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-21

3.  Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma.

Authors:  C Zhang; C Li; X Chen; Y Zhou; B Yin; R Ni; Y Zhang; J Liu
Journal:  Clin Transl Oncol       Date:  2017-06-06       Impact factor: 3.405

4.  Serine/threonine-protein kinase PFTK1 modulates oligodendrocyte differentiation via PI3K/AKT pathway.

Authors:  Hai Jie Yang; Lei Wang; Mian Wang; Shuang Ping Ma; Bin Feng Cheng; Zhi Chao Li; Zhi Wei Feng
Journal:  J Mol Neurosci       Date:  2014-10-30       Impact factor: 3.444

5.  The role of lncRNA MSC-AS1/miR-29b-3p axis-mediated CDK14 modulation in pancreatic cancer proliferation and Gemcitabine-induced apoptosis.

Authors:  Yunpeng Sun; Pengfei Wang; Wenjun Yang; Yunfeng Shan; Qiyu Zhang; Huanhuan Wu
Journal:  Cancer Biol Ther       Date:  2019-03-27       Impact factor: 4.742

6.  Cyclin Y regulates the proliferation, migration, and invasion of ovarian cancer cells via Wnt signaling pathway.

Authors:  Haiyuan Liu; Honghui Shi; Qingbo Fan; Xiangxiu Sun
Journal:  Tumour Biol       Date:  2016-01-29

7.  Knockdown of PFTK1 inhibits tumor cell proliferation, invasion and epithelial-to-mesenchymal transition in pancreatic cancer.

Authors:  Li Zheng; Zhongyong Zhou; Zhikuan He
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

8.  CDK14 involvement in proliferation migration and invasion of esophageal cancer.

Authors:  Lingling Chen; Yayun Wang; Wenyan Jiang; Runzhou Ni; Yuchan Wang; Sujie Ni
Journal:  Ann Transl Med       Date:  2019-11

Review 9.  Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Authors:  Steven R Whittaker; Aurélie Mallinger; Paul Workman; Paul A Clarke
Journal:  Pharmacol Ther       Date:  2017-02-05       Impact factor: 12.310

10.  Cytoplasmic Localization Isoform of Cyclin Y Enhanced the Metastatic Ability of Lung Cancer via Regulating Tropomyosin 4.

Authors:  Xiaoting Zhao; Mei Jiang; Yu Teng; Jie Li; Zhefeng Li; Wende Hao; Hongyu Zhao; Chenghong Yin; Wentao Yue
Journal:  Front Cell Dev Biol       Date:  2021-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.